We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Intoware provide wearable, mobile and desktop technology to SME's and SAS clients. Intoware digitise the deskless workspace and therefore remove the need for paper checklists. Once a checklist is complete, Intoware is able to share the completed list with anyone it may concern.
days to go: Expired investment: £700,000
Twisted Mirror TV (TMTV) is a comedy streaming service dedicated to short-form content, developed for several platforms such as desktop, iOS and Android. The platform has been live since August 2019 and offers free and unlimited access to international comedy including short series, sketches and stand-up comedy. The service is at the pre-revenue stage with payment solutions and an ad-serving engine in place. TMTV has signed agreements with existing mobile providers such as Vodafone, Huawei and EE to use their network base and add incremental value to its platform's services. TMTV believes this strategy will give rapid access to millions of potential customers and grow its business.
days to go: Expired investment: Withheld
Tamoco Limited are a provider of online data, creating actionable data and aggregating precise consumer location data. Tamoco provides brands with a method of understanding how audiences behave with speed and accuracy, and delivers an innovative content delivery platform for advertisers. The platform utilises precise location to present content relevant to its audience.     
days to go: Expired investment: £1,050,000
Plantwork Systems (PWS) is an eco-conscious, technology company providing sustainable and environmentally friendly solutions to the wastewater treatment industry. It is the developer, owner, and provider of a range of proprietary technologies such as TN-REM, NUTREM®, and the deHoxar Spiral Separator. These products aid in nutrient removal, improved filtration, sludge thickening. This leads to wastewater treatment plants recycling more water, reducing their energy requirements, and minimising water scarcity. The company has generated combined revenues of £1.44 million since July 2017. PWS is seeking funding of up to £1 million, at a pre-money valuation of £6 million. It will use the investment to accelerate its growth and bring more innovative products to the market. 

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £244,865
Goldilock empowers remote, instant control of physical connections and disconnections for assets, devices, data, and network segments – all without internet dependency. Addressing the vulnerabilities of the Cloud and emerging technologies, Goldilock provides a solution that leverages physical disconnection, offering heightened cybersecurity. With the endorsement of experts like Gregory Akers from CISCO, Goldilock excels in securing IP-based network components, achieving unmatched security through on-demand isolation or connection that remains unseen by cyber threats.
days to go: Expired investment: £200,000
PyroCore is a waste-to-energy technology company. Its technology, Pyrolisis, burns waste and sludge for 30 minutes at 700-900 degree celsius in the absence of oxygen, which leads to reduction of waste volume by 90%, and the energy output can be used for heat, steam or power generation. It also eliminates the need for landfill sites, reduces carbon emissions, and helps businesses cut down on landfill taxes. The company has partnered with institutions such as Brunel University London and The Association for Renewable Energy and Technology. It has also contributed to charities such as Fresh Water Habitats, ALK Positive UK, and others. It is seeking support for deployment of its technology on sites where safe and easy disposal of hazardous or infectious waste can be undertaken, especially in the wake of Covid-19.
days to go: Expired investment: Withheld
The Stirling Electric Motorcycle Company presents a futuristic motorcycle experience available today! The SEMC "SINATRA" delivers an exhilarating ride, easy maintenance, and the finest ride quality in its category. Whether you're a new, returning, or transitioning rider, enjoy the benefits of electric riding without the complexities and costs of advanced licensing. In numerous regions, motorcycles with up to 11 kilowatts of continuous power have more lenient licensing rules, such as in the UK where an 11kw SINATRA can be legally ridden after completing a one-day basic training course.
days to go: Expired investment: £42,000
Antikor is developing a new cancer treatment using antibody fragment drug conjugate which penetrates solid tumours to destroy cancer cells. Their new treatment only targets pre-determined cancer cells, so healthy cells are not affected.  Biopharma is predicted to become the core of the pharmaceutical industry after undergoing transformation in the laboratory, technology and operations  
days to go: Expired investment: £125,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph